4-Hydroxybutyric Acid
The risk or severity of adverse effects can be increased when Gamma Hydroxybutyric Acid is combined with Gabapentin Enacarbil.
Acepromazine
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Acepromazine.
Aceprometazine
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Aceprometazine.
Advertisement
Alfaxalone
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Alfaxalone.
Alfentanil
The risk or severity of adverse effects can be increased when Alfentanil is combined with Gabapentin Enacarbil.
Alphaprodine
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Alphaprodine.
Advertisement
Alprazolam
The risk or severity of adverse effects can be increased when Alprazolam is combined with Gabapentin Enacarbil.
Amisulpride
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Amisulpride.
Amitriptyline
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Gabapentin Enacarbil.
Advertisement
Amobarbital
The risk or severity of adverse effects can be increased when Amobarbital is combined with Gabapentin Enacarbil.
Amoxapine
The risk or severity of adverse effects can be increased when Amoxapine is combined with Gabapentin Enacarbil.
Aripiprazole
The risk or severity of adverse effects can be increased when Aripiprazole is combined with Gabapentin Enacarbil.
Articaine
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Articaine.
Asenapine
The risk or severity of adverse effects can be increased when Asenapine is combined with Gabapentin Enacarbil.
Azelastine
Gabapentin Enacarbil may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Baclofen
The risk or severity of adverse effects can be increased when Baclofen is combined with Gabapentin Enacarbil.
Barbital
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Barbital.
Benoxinate
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Oxybuprocaine.
Benperidol
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Benperidol.
Benzocaine
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Benzocaine.
Benzyl Alcohol
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Benzyl alcohol.
Brexpiprazole
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Brexpiprazole.
Brimonidine
Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Gabapentin Enacarbil.
Bromazepam
The risk or severity of adverse effects can be increased when Bromazepam is combined with Gabapentin Enacarbil.
Bromperidol
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Bromperidol.
Brompheniramine
The risk or severity of adverse effects can be increased when Brompheniramine is combined with Gabapentin Enacarbil.
Brotizolam
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Brotizolam.
Bupivacaine
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Bupivacaine.
Buprenorphine
Gabapentin Enacarbil may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Buspirone
The risk or severity of adverse effects can be increased when Buspirone is combined with Gabapentin Enacarbil.
Butabarbital
The risk or severity of adverse effects can be increased when Butabarbital is combined with Gabapentin Enacarbil.
Butalbital
The risk or severity of adverse effects can be increased when Butalbital is combined with Gabapentin Enacarbil.
Butamben
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Butamben.
Butobarbital
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Butethal.
Butorphanol
The risk or severity of adverse effects can be increased when Butorphanol is combined with Gabapentin Enacarbil.
Carbamazepine
The risk or severity of adverse effects can be increased when Carbamazepine is combined with Gabapentin Enacarbil.
Carbinoxamine
The risk or severity of adverse effects can be increased when Carbinoxamine is combined with Gabapentin Enacarbil.
Carisoprodol
The risk or severity of adverse effects can be increased when Carisoprodol is combined with Gabapentin Enacarbil.
Cetirizine
The risk or severity of adverse effects can be increased when Cetirizine is combined with Gabapentin Enacarbil.
Chloral Hydrate
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Chloral hydrate.
Chlordiazepoxide
The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Gabapentin Enacarbil.
Chlormethiazole
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with clomethiazole.
Chlormezanone
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Chlormezanone.
Chloroprocaine
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Chloroprocaine.
Chlorpheniramine
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Gabapentin Enacarbil.
CHLORPHENIRAMINE POLISTIREX
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Gabapentin Enacarbil.
Chlorpromazine
The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Gabapentin Enacarbil.
Chlorprothixene
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Chlorprothixene.
Chlorzoxazone
The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Gabapentin Enacarbil.
Citalopram
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Citalopram.
Clemastine
The risk or severity of adverse effects can be increased when Clemastine is combined with Gabapentin Enacarbil.
Clidinium
The risk or severity of adverse effects can be increased when Clidinium is combined with Gabapentin Enacarbil.
Clidinium bromide
The risk or severity of adverse effects can be increased when Clidinium is combined with Gabapentin Enacarbil.
Clobazam
The risk or severity of adverse effects can be increased when Clobazam is combined with Gabapentin Enacarbil.
Clomipramine
The risk or severity of adverse effects can be increased when Clomipramine is combined with Gabapentin Enacarbil.
Clonazepam
The risk or severity of adverse effects can be increased when Clonazepam is combined with Gabapentin Enacarbil.
Clonidine
The risk or severity of adverse effects can be increased when Clonidine is combined with Gabapentin Enacarbil.
Clorazepate
The risk or severity of adverse effects can be increased when Clorazepate is combined with Gabapentin Enacarbil.
CLORAZEPIC ACID
The risk or severity of adverse effects can be increased when Clorazepate is combined with Gabapentin Enacarbil.
Clozapine
The risk or severity of adverse effects can be increased when Clozapine is combined with Gabapentin Enacarbil.
Cocaine
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Cocaine.
Codeine
The risk or severity of adverse effects can be increased when Codeine is combined with Gabapentin Enacarbil.
Codeine Anhydrous
The risk or severity of adverse effects can be increased when Codeine is combined with Gabapentin Enacarbil.
CODEINE POLISTIREX
The risk or severity of adverse effects can be increased when Codeine is combined with Gabapentin Enacarbil.
Cyclizine
The risk or severity of adverse effects can be increased when Cyclizine is combined with Gabapentin Enacarbil.
Cyclobenzaprine
The risk or severity of adverse effects can be increased when Cyclobenzaprine is combined with Gabapentin Enacarbil.
Cyproheptadine
The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Gabapentin Enacarbil.
Dantrolene
The risk or severity of adverse effects can be increased when Dantrolene is combined with Gabapentin Enacarbil.
Dapiprazole
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Dapiprazole.
Desflurane
The risk or severity of adverse effects can be increased when Desflurane is combined with Gabapentin Enacarbil.
Desipramine
The risk or severity of adverse effects can be increased when Desipramine is combined with Gabapentin Enacarbil.
Desloratadine
The risk or severity of adverse effects can be increased when Desloratadine is combined with Gabapentin Enacarbil.
Desvenlafaxine
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Desvenlafaxine.
Dexbrompheniramine
The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Gabapentin Enacarbil.
Dexmedetomidine
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Dexmedetomidine.
Dextromoramide
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Dextromoramide.
Dezocine
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Dezocine.
Diazepam
The risk or severity of adverse effects can be increased when Diazepam is combined with Gabapentin Enacarbil.
Dibucaine
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Cinchocaine.
Difenoxin
The risk or severity of adverse effects can be increased when Difenoxin is combined with Gabapentin Enacarbil.
Dihydrocodeine
The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Gabapentin Enacarbil.
Dimenhydrinate
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Gabapentin Enacarbil.
Diphenhydramine
The risk or severity of adverse effects can be increased when Diphenhydramine is combined with Gabapentin Enacarbil.
Diphenoxylate
The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Gabapentin Enacarbil.
Doxepin
The risk or severity of adverse effects can be increased when Doxepin is combined with Gabapentin Enacarbil.
Doxylamine
Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Gabapentin Enacarbil.
Droperidol
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Gabapentin Enacarbil.
Duloxetine
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Duloxetine.
Dyclonine
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Dyclonine.
Efavirenz
The risk or severity of adverse effects can be increased when Efavirenz is combined with Gabapentin Enacarbil.
Enflurane
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Enflurane.
Entacapone
The risk or severity of adverse effects can be increased when Entacapone is combined with Gabapentin Enacarbil.
Escitalopram
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Escitalopram.
Estazolam
The risk or severity of adverse effects can be increased when Estazolam is combined with Gabapentin Enacarbil.
Eszopiclone
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Gabapentin Enacarbil.
Ethanol
Ethanol may increase the central nervous system depressant (CNS depressant) activities of Gabapentin Enacarbil.
Ethchlorvynol
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Ethchlorvynol.
Ethosuximide
The risk or severity of adverse effects can be increased when Ethosuximide is combined with Gabapentin Enacarbil.
Ethotoin
The risk or severity of adverse effects can be increased when Ethotoin is combined with Gabapentin Enacarbil.
Ethyl Chloride
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Ethyl chloride.
Ethyl Loflazepate
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Ethyl loflazepate.
Ethylmorphine
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Ethylmorphine.
Etidocaine
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Etidocaine.
Etifoxine
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Etifoxine.
Etomidate
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Etomidate.
Ezogabine
The risk or severity of adverse effects can be increased when Ezogabine is combined with Gabapentin Enacarbil.
Felbamate
The risk or severity of adverse effects can be increased when Felbamate is combined with Gabapentin Enacarbil.
Fentanyl
The risk or severity of adverse effects can be increased when Fentanyl is combined with Gabapentin Enacarbil.
Fexofenadine
The risk or severity of adverse effects can be increased when Fexofenadine is combined with Gabapentin Enacarbil.
Flibanserin
The risk or severity of adverse effects can be increased when Flibanserin is combined with Gabapentin Enacarbil.
Flunarizine
The risk or severity of adverse effects can be increased when Flunarizine is combined with Gabapentin Enacarbil.
Flunitrazepam
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Flunitrazepam.
Fluoxetine
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Fluoxetine.
Flupenthixol
The risk or severity of adverse effects can be increased when Flupentixol is combined with Gabapentin Enacarbil.
Fluphenazine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Gabapentin Enacarbil.
Flurazepam
The risk or severity of adverse effects can be increased when Flurazepam is combined with Gabapentin Enacarbil.
Fluspirilene
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Fluspirilene.
Fluticasone propionate
The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Gabapentin Enacarbil.
Fluvoxamine
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Fluvoxamine.
Fosphenytoin
The risk or severity of adverse effects can be increased when Fosphenytoin is combined with Gabapentin Enacarbil.
Fospropofol
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Fospropofol.
Gabapentin
The risk or severity of adverse effects can be increased when Gabapentin is combined with Gabapentin Enacarbil.
Glutethimide
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Glutethimide.
Guanfacine
The risk or severity of adverse effects can be increased when Guanfacine is combined with Gabapentin Enacarbil.
Halazepam
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Halazepam.
Haloperidol
The risk or severity of adverse effects can be increased when Haloperidol is combined with Gabapentin Enacarbil.
Halothane
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Halothane.
Heroin
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Heroin.
Hexobarbital
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Hexobarbital.
Hydrocodone
Gabapentin Enacarbil may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
HYDROCODONE POLISTIREX
Gabapentin Enacarbil may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Hydromorphone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Gabapentin Enacarbil.
Hydroxyzine
Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Gabapentin Enacarbil.
Iloperidone
The risk or severity of adverse effects can be increased when Iloperidone is combined with Gabapentin Enacarbil.
Imipramine
The risk or severity of adverse effects can be increased when Imipramine is combined with Gabapentin Enacarbil.
Isoflurane
The risk or severity of adverse effects can be increased when Isoflurane is combined with Gabapentin Enacarbil.
Ketamine
The risk or severity of adverse effects can be increased when Ketamine is combined with Gabapentin Enacarbil.
Ketazolam
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Ketazolam.
Lamotrigine
The risk or severity of adverse effects can be increased when Lamotrigine is combined with Gabapentin Enacarbil.
Levetiracetam
The risk or severity of adverse effects can be increased when Levetiracetam is combined with Gabapentin Enacarbil.
Levobupivacaine
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Levobupivacaine.
Levocabastine
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Levocabastine.
Levocetirizine
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Gabapentin Enacarbil.
Levodopa
The risk or severity of adverse effects can be increased when Levodopa is combined with Gabapentin Enacarbil.
Levomethadyl
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Levomethadyl Acetate.
Levomilnacipran
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Levomilnacipran.
Levorphanol
The risk or severity of adverse effects can be increased when Levorphanol is combined with Gabapentin Enacarbil.
Lidocaine
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Lidocaine.
Lithium
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Lithium.
Lithium Cation
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Lithium.
Lofexidine
The therapeutic efficacy of Gabapentin Enacarbil can be increased when used in combination with Lofexidine.
Loratadine
The risk or severity of adverse effects can be increased when Loratadine is combined with Gabapentin Enacarbil.
Lorazepam
The risk or severity of adverse effects can be increased when Lorazepam is combined with Gabapentin Enacarbil.
Lormetazepam
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Lormetazepam.
Loxapine
The risk or severity of adverse effects can be increased when Loxapine is combined with Gabapentin Enacarbil.
Lurasidone
The risk or severity of adverse effects can be increased when Lurasidone is combined with Gabapentin Enacarbil.
Magnesium Sulfate
The therapeutic efficacy of Gabapentin Enacarbil can be increased when used in combination with Magnesium sulfate.
MAGNESIUM SULFATE ANHYDROUS
The therapeutic efficacy of Gabapentin Enacarbil can be increased when used in combination with Magnesium sulfate.
Maprotiline
The risk or severity of adverse effects can be increased when Maprotiline is combined with Gabapentin Enacarbil.
Meclizine
The risk or severity of adverse effects can be increased when Meclizine is combined with Gabapentin Enacarbil.
Melatonin
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Melatonin.
Meperidine
The risk or severity of adverse effects can be increased when Pethidine is combined with Gabapentin Enacarbil.
Mephobarbital
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Methylphenobarbital.
Mepivacaine
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Mepivacaine.
Meprobamate
The risk or severity of adverse effects can be increased when Meprobamate is combined with Gabapentin Enacarbil.
Mesoridazine
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Mesoridazine.
Metaxalone
The risk or severity of adverse effects can be increased when Metaxalone is combined with Gabapentin Enacarbil.
Methadone
The risk or severity of adverse effects can be increased when Methadone is combined with Gabapentin Enacarbil.
Methadyl Acetate
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Methadyl Acetate.
Methapyrilene
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Methapyrilene.
Methaqualone
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Methaqualone.
Methocarbamol
The risk or severity of adverse effects can be increased when Methocarbamol is combined with Gabapentin Enacarbil.
Methohexital
The risk or severity of adverse effects can be increased when Methohexital is combined with Gabapentin Enacarbil.
Methotrimeprazine
Gabapentin Enacarbil may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Methoxyflurane
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Methoxyflurane.
Methsuximide
The risk or severity of adverse effects can be increased when Methsuximide is combined with Gabapentin Enacarbil.
Metylperon
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Melperone.
Metyrosine
Gabapentin Enacarbil may increase the sedative activities of Metyrosine.
Midazolam
The risk or severity of adverse effects can be increased when Midazolam is combined with Gabapentin Enacarbil.
Milnacipran
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Milnacipran.
Minocycline
Minocycline may increase the central nervous system depressant (CNS depressant) activities of Gabapentin Enacarbil.
Mirtazapine
Gabapentin Enacarbil may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.
Molindone
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Molindone.
Morphine
The risk or severity of adverse effects can be increased when Morphine is combined with Gabapentin Enacarbil.
Nabilone
Nabilone may increase the central nervous system depressant (CNS depressant) activities of Gabapentin Enacarbil.
Nalbuphine
The risk or severity of adverse effects can be increased when Nalbuphine is combined with Gabapentin Enacarbil.
Nefazodone
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Nefazodone.
Nitrazepam
The risk or severity of adverse effects can be increased when Nitrazepam is combined with Gabapentin Enacarbil.
Nitrous Oxide
The risk or severity of adverse effects can be increased when Nitrous oxide is combined with Gabapentin Enacarbil.
Nordazepam
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Nordazepam.
Norflurane
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Norflurane.
Normethadone
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Normethadone.
Nortriptyline
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Gabapentin Enacarbil.
Olanzapine
The risk or severity of adverse effects can be increased when Olanzapine is combined with Gabapentin Enacarbil.
Olopatadine
The risk or severity of adverse effects can be increased when Olopatadine is combined with Gabapentin Enacarbil.
Ondansetron
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Ondansetron.
Opium
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Opium.
Orphenadrine
Gabapentin Enacarbil may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Oxazepam
The risk or severity of adverse effects can be increased when Oxazepam is combined with Gabapentin Enacarbil.
Oxprenolol
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Oxprenolol.
Oxycodone
The risk or severity of adverse effects can be increased when Oxycodone is combined with Gabapentin Enacarbil.
Oxymorphone
The risk or severity of adverse effects can be increased when Oxymorphone is combined with Gabapentin Enacarbil.
Paliperidone
The risk or severity of adverse effects can be increased when Paliperidone is combined with Gabapentin Enacarbil.
Paraldehyde
Gabapentin Enacarbil may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Paregoric
The risk or severity of adverse effects can be increased when Morphine is combined with Gabapentin Enacarbil.
Paroxetine
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Paroxetine.
Pentazocine
The risk or severity of adverse effects can be increased when Pentazocine is combined with Gabapentin Enacarbil.
Pentobarbital
The risk or severity of adverse effects can be increased when Pentobarbital is combined with Gabapentin Enacarbil.
Perampanel
Perampanel may increase the central nervous system depressant (CNS depressant) activities of Gabapentin Enacarbil.
Perazine
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Perazine.
Perphenazine
The risk or severity of adverse effects can be increased when Perphenazine is combined with Gabapentin Enacarbil.
Phenobarbital
The risk or severity of adverse effects can be increased when Phenobarbital is combined with Gabapentin Enacarbil.
Phenoxyethanol
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Phenoxyethanol.
Phenytoin
The risk or severity of adverse effects can be increased when Phenytoin is combined with Gabapentin Enacarbil.
Pimozide
The risk or severity of adverse effects can be increased when Pimozide is combined with Gabapentin Enacarbil.
Pipamperone
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Pipamperone.
Pipothiazine
The risk or severity of adverse effects can be increased when Pipotiazine is combined with Gabapentin Enacarbil.
Pirinitramide
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Piritramide.
Pizotyline
The risk or severity of adverse effects can be increased when Pizotifen is combined with Gabapentin Enacarbil.
Pomalidomide
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Pomalidomide.
Pramipexole
Gabapentin Enacarbil may increase the sedative activities of Pramipexole.
Pramoxine
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Pramocaine.
Prazepam
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Prazepam.
Pregabalin
The therapeutic efficacy of Gabapentin Enacarbil can be increased when used in combination with Pregabalin.
Prilocaine
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Prilocaine.
Primidone
The risk or severity of adverse effects can be increased when Primidone is combined with Gabapentin Enacarbil.
Procaine
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Procaine.
Prochlorperazine
The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Gabapentin Enacarbil.
Promazine
The risk or severity of adverse effects can be increased when Promazine is combined with Gabapentin Enacarbil.
Promethazine
The risk or severity of adverse effects can be increased when Promethazine is combined with Gabapentin Enacarbil.
Proparacaine
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Proparacaine.
Propofol
The risk or severity of adverse effects can be increased when Propofol is combined with Gabapentin Enacarbil.
Propoxyphene
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Dextropropoxyphene.
Protriptyline
The risk or severity of adverse effects can be increased when Protriptyline is combined with Gabapentin Enacarbil.
Quazepam
The risk or severity of adverse effects can be increased when Quazepam is combined with Gabapentin Enacarbil.
Quetiapine
The risk or severity of adverse effects can be increased when Quetiapine is combined with Gabapentin Enacarbil.
Quetiapine fumarate
The risk or severity of adverse effects can be increased when Quetiapine is combined with Gabapentin Enacarbil.
Ramelteon
The risk or severity of adverse effects can be increased when Ramelteon is combined with Gabapentin Enacarbil.
Remifentanil
The risk or severity of adverse effects can be increased when Remifentanil is combined with Gabapentin Enacarbil.
Remoxipride
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Remoxipride.
Reserpine
The risk or severity of adverse effects can be increased when Reserpine is combined with Gabapentin Enacarbil.
Risperidone
The risk or severity of adverse effects can be increased when Risperidone is combined with Gabapentin Enacarbil.
Ropinirole
Gabapentin Enacarbil may increase the sedative activities of Ropinirole.
Ropivacaine
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Ropivacaine.
Rotigotine
Gabapentin Enacarbil may increase the sedative activities of Rotigotine.
Rufinamide
The risk or severity of adverse effects can be increased when Rufinamide is combined with Gabapentin Enacarbil.
Scopolamine
The risk or severity of adverse effects can be increased when Scopolamine is combined with Gabapentin Enacarbil.
Scopolamine Hydrobromide
The risk or severity of adverse effects can be increased when Scopolamine is combined with Gabapentin Enacarbil.
Secobarbital
The risk or severity of adverse effects can be increased when Secobarbital is combined with Gabapentin Enacarbil.
Sertindole
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Sertindole.
Sertraline
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Sertraline.
Sevoflurane
The risk or severity of adverse effects can be increased when Sevoflurane is combined with Gabapentin Enacarbil.
Sodium Oxybate
Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Gabapentin Enacarbil.
Sufentanil
The risk or severity of adverse effects can be increased when Sufentanil is combined with Gabapentin Enacarbil.
Sulpiride
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Sulpiride.
Suvorexant
Gabapentin Enacarbil may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Tapentadol
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Gabapentin Enacarbil.
Tasimelteon
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Tasimelteon.
Temazepam
The risk or severity of adverse effects can be increased when Temazepam is combined with Gabapentin Enacarbil.
Tetrabenazine
The risk or severity of adverse effects can be increased when Tetrabenazine is combined with Gabapentin Enacarbil.
Tetracaine
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Tetracaine.
Tetracaine hydrochloride
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Tetracaine.
Tetrahydrocannabinol
Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Gabapentin Enacarbil.
Thalidomide
Gabapentin Enacarbil may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Thiamylal
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Thiamylal.
Thiopental
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Thiopental.
Thiopental Sodium
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Thiopental.
Thioridazine
The risk or severity of adverse effects can be increased when Thioridazine is combined with Gabapentin Enacarbil.
Thiothixene
The risk or severity of adverse effects can be increased when Thiothixene is combined with Gabapentin Enacarbil.
Tiagabine
The risk or severity of adverse effects can be increased when Tiagabine is combined with Gabapentin Enacarbil.
Tiapride
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Tiapride.
Tizanidine
The risk or severity of adverse effects can be increased when Tizanidine is combined with Gabapentin Enacarbil.
Tolcapone
The risk or severity of adverse effects can be increased when Tolcapone is combined with Gabapentin Enacarbil.
Topiramate
The risk or severity of adverse effects can be increased when Topiramate is combined with Gabapentin Enacarbil.
Tramadol
The risk or severity of adverse effects can be increased when Tramadol is combined with Gabapentin Enacarbil.
Tranylcypromine
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Tranylcypromine.
Trazodone
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Trazodone.
Triazolam
The risk or severity of adverse effects can be increased when Triazolam is combined with Gabapentin Enacarbil.
Triazulenone
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Loprazolam.
Trifluoperazine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Gabapentin Enacarbil.
Triflupromazine
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Triflupromazine.
Trimipramine
The risk or severity of adverse effects can be increased when Trimipramine is combined with Gabapentin Enacarbil.
Triprolidine
The risk or severity of adverse effects can be increased when Triprolidine is combined with Gabapentin Enacarbil.
Urethane
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Ethyl carbamate.
Valproate
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Valproic Acid.
Valproic Acid
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Valproic Acid.
Venlafaxine
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Venlafaxine.
Vigabatrin
The risk or severity of adverse effects can be increased when Vigabatrin is combined with Gabapentin Enacarbil.
Vortioxetine
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Vortioxetine.
Xylazine
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Xylazine.
Zaleplon
The risk or severity of adverse effects can be increased when Zaleplon is combined with Gabapentin Enacarbil.
Ziconotide
The risk or severity of adverse effects can be increased when Ziconotide is combined with Gabapentin Enacarbil.
Ziprasidone
The risk or severity of adverse effects can be increased when Ziprasidone is combined with Gabapentin Enacarbil.
Zolpidem
Gabapentin Enacarbil may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Zonisamide
The risk or severity of adverse effects can be increased when Zonisamide is combined with Gabapentin Enacarbil.
Zopiclone
The risk or severity of adverse effects can be increased when Zopiclone is combined with Gabapentin Enacarbil.
Zotepine
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Zotepine.
Zuclopenthixol
The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Gabapentin Enacarbil.
